Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
JBR-BTR ; 95(5): 297-9, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-23198368

RESUMO

Hydatid disease (HD) is a unique parasitic infection that is endemic in many parts of the world. Although the disease primarly affects the liver, HD can be encountered almost anywhere in the body depending on its hematogenous dissemination. In this case report, we describe a 61-year-old man who presented with abdominal pain and urinary complaints. Imaging studies revealed a huge liver and pelvic region lesions that exhibited characteristic imaging findings for type 3 HD.The second lesion was interpreted as occurring due to dissemination from the liver HD. Due to the extensiveness of the disease, both surgery and percutaneous drainage of the lesions were excluded and the patient was put on albendazole treatment.


Assuntos
Dor Abdominal/parasitologia , Equinococose Hepática/diagnóstico , Albendazol/uso terapêutico , Anti-Helmínticos/uso terapêutico , Diagnóstico Diferencial , Diagnóstico por Imagem , Equinococose Hepática/tratamento farmacológico , Humanos , Masculino , Pessoa de Meia-Idade
3.
Phys Rev Lett ; 100(17): 172501, 2008 May 02.
Artigo em Inglês | MEDLINE | ID: mdl-18518283

RESUMO

Inclusive inelastic electron scattering off the deuteron under 180 degrees has been studied at the S-DALINAC close to the breakup threshold at momentum transfers q=0.27 fm;{-1} and 0.74 fm;{-1} with good energy resolution sufficient to map in detail the spin flip M1 response, which governs the starting reaction pn-->dgamma of big-bang nucleosynthesis over most of the relevant temperature region. Results from potential model calculations and (for q=0.27 fm;{-1}) from pionless nuclear effective field theory are in excellent agreement with the data.

4.
Biochem Mol Med ; 59(2): 174-81, 1996 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-8986641

RESUMO

Recent studies have suggested that the insulin receptor tyrosine kinase inhibitor, membrane glycoprotein PC-1, may play a role in certain insulin resistant states. In the present study, we examined whether either insulin receptor function or PC-1 activity was altered during the development of insulin resistance that occurs with high fat feeding in normal rats. Over the course of 14 days of high fat feeding, both maximal and submaximal (physiological) insulin-stimulated skeletal muscle glucose uptake decreased gradually; after 14 days of high fat feeding, submaximal and maximal insulin-stimulated glucose uptake decreased by approximately 40 and approximately 50%, respectively. In contrast, in the same muscles (tibialis anterior) of these animals, neither insulin receptor content nor insulin-stimulated insulin receptor autophosphorylation was altered after 14 days of high fat feeding. PC-1 has both nucleotide pyrophosphatase (EC 3.6.1.9) and alkaline phosphodiesterase I (EC 3.1.4.1) enzyme activities. These enzyme activities showed no changes during the course of 14 days of high fat feeding. Individual data revealed that there was no significant correlation between insulin-stimulated glucose uptake and alkaline phosphodiesterase or nucleotide pyrophosphatase activity (P > 0.05). Together, these data indicate that neither defects in insulin receptor function nor elevated PC-1 activities are involved in the development of insulin resistance in rats with high fat feeding, and the insulin resistance induced with high fat feeding is likely due to postreceptor defects in skeletal muscle.


Assuntos
Gorduras na Dieta/administração & dosagem , Resistência à Insulina , Glicoproteínas de Membrana/metabolismo , Diester Fosfórico Hidrolases , Pirofosfatases , Receptor de Insulina/metabolismo , Animais , Insulina/fisiologia , Masculino , Glicoproteínas de Membrana/antagonistas & inibidores , Ratos , Ratos Wistar , Receptor de Insulina/antagonistas & inibidores
5.
Invest Ophthalmol Vis Sci ; 36(7): 1433-40, 1995 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-7775121

RESUMO

PURPOSE: The myotoxic drug doxorubicin can treat blepharospasm and hemifacial spasm permanently when injected directly into the eyelid of patients. One side effect of this treatment is the dose-related occurrence of injury to the skin overlying the injection site. The purpose of this study was to determine if injection of the immunosuppressive agent cyclosporin into rabbit eyelids before doxorubicin treatment could reduce the occurrence of injury to the overlying skin and to determine the effect of cyclosporin pretreatment on doxorubicin-induced muscle fiber loss. METHODS: Anesthetized rabbits received injections of varying doses of cyclosporin 20 minutes before injection of either 0.5, 1, or 2 mg doxorubicin. The rabbits were examined daily, and epithelial changes were recorded as to duration, time of onset, and healing. When the skin was completely healed, the animals were killed and eyelid tissue was prepared for morphometric determination of muscle fiber number. Acute inflammation was quantitatively assessed using an Evans blue assay. RESULTS: At specified doses, cyclosporin improved the doxorubicin chemomyectomy protocol in three ways. It delayed the onset of skin injury at the higher doses of doxorubicin, and it markedly decreased the duration of skin injury. At some doses, cyclosporin completely prevented the formation of epithelial defects. The combination, however, did not increase muscle loss compared to doxorubicin alone; in fact, it had a slightly myoprotective effect. A dose range for cyclosporin administration was determined that resulted in a quantitative and dose-dependent reduction in inflammation at the injection site. CONCLUSIONS: The injection of cyclosporin into the eyelids before doxorubicin treatment delayed the onset, reduced the duration, and limited the extent of development of eyelid skin injury. Perhaps by limiting cytokine release, cyclosporin decreased the inflammatory reaction compared to that seen with doxorubicin alone. This combination has the potential to improve patient acceptance of doxorubicin chemomyectomy for the treatment of blepharospasm and hemifacial spasm.


Assuntos
Ciclosporina/uso terapêutico , Doxorrubicina/efeitos adversos , Doenças Palpebrais/prevenção & controle , Dermatopatias/prevenção & controle , Animais , Blefarospasmo/tratamento farmacológico , Ciclosporina/administração & dosagem , Doxorrubicina/uso terapêutico , Doenças Palpebrais/induzido quimicamente , Pálpebras/efeitos dos fármacos , Músculos Faciais/efeitos dos fármacos , Injeções , Denervação Muscular/métodos , Músculos Oculomotores/efeitos dos fármacos , Coelhos , Pele/efeitos dos fármacos , Dermatopatias/induzido quimicamente , Espasmo/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...